This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Maintenance treatment in acne vulgaris

Authoring team

Maintenance treatment in acne vulgaris

Encourage continued appropriate skin care

  • advise people with acne to use a non-alkaline (skin pH neutral or slightly acidic) synthetic detergent (syndet) cleansing product twice daily on acne-prone skin
  • advise people with acne who use skin care products (for example, moisturisers) and sunscreens to avoid oil-based and comedogenic preparations
  • advise people with acne who use make-up to avoid oil-based and comedogenic products, and to remove make-up at the end of the day
  • advise people that persistent picking or scratching of acne lesions can increase the risk of scarring

Explain to the person with acne that, after completion of treatment, maintenance treatment is not always necessary.

Explain to the person with acne that, after completion of treatment, maintenance treatment is not always necessary.

Consider maintenance treatment in people with a history of frequent relapse after treatment.

Consider a fixed combination of topical adapalene and topical benzoyl peroxide as maintenance treatment for acne. If this is not tolerated, or if 1 component of the combination is contraindicated, consider topical monotherapy with adapalene, azelaic acid, or benzoyl peroxide

Reference:

National Institute for Health and Care Excellence. Acne vulgaris: management. Dec 2023 [internet publication]


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.